in this update overview management discussion and review of performance financial & operating business wise wockhardt medical excellence awards conclusion investor communication is committed to keeping its investors constantly informed about ongoing corporate developments covers the company s for period ended 31st march 2003 we would appreciate your feedback any additional questions information requests can be addressed ashish kakabalia pratik basu roy limited tel 91 22 2653 4444 8054 8013 fax 4242 e mail akakabalia com proy one india premier research technology oriented focussed pharmaceutical major has an active multi disciplinary r&d programme with around 350 scientists it been frontrunner biotechnology country led by a competent team who have developed comprehensive capabilities from concept market two immensely successful products several others pipeline focussing on developing ndds aimed largely towards markets us europe
